Fraport AG (ETR:FRA)

CTI BioPharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,987	5,405	5,059	3,515	5,468	4,560
Market Cap Growth	18.40%	6.83%	43.92%	-35.70%	19.89%	-34.86%
Enterprise Value	15,527	14,435	13,684	11,816	12,440	10,166
Last Close Price	64.80	58.50	54.76	38.05	59.18	49.36
PE Ratio	14.32	12.00	12.87	26.55	66.04	-
Forward PE	14.32	13.79	12.10	13.17	29.71	-
PS Ratio	1.34	1.20	1.25	1.09	2.51	2.66
PB Ratio	1.17	1.04	1.10	0.85	1.40	1.21
P/TBV Ratio	41.81	33.12	91.00	140.06	25.84	17.59
P/FCF Ratio	-	-	-	76.93	-	-
P/OCF Ratio	5.81	4.58	5.86	4.47	13.93	-
PEG Ratio	4.73	6.88	0.23	0.21	-	-
EV/Sales Ratio	3.48	3.22	3.38	3.65	5.70	5.93
EV/EBITDA Ratio	12.19	11.95	12.16	13.63	32.05	-
EV/EBIT Ratio	20.83	20.30	20.69	26.28	-	-
EV/FCF Ratio	-86.12	-	-	258.56	-	-
Debt / Equity Ratio	2.38	2.41	2.60	2.70	2.61	2.14
Debt / EBITDA Ratio	9.91	10.03	10.26	12.26	23.98	2876.36
Debt / FCF Ratio	-	-	-	243.66	-	-
Asset Turnover	0.23	0.23	0.22	0.19	0.14	0.13
Inventory Turnover	119.93	115.68	101.43	93.38	76.76	69.79
Quick Ratio	1.60	1.48	1.40	1.40	2.12	1.19
Current Ratio	1.61	1.61	1.49	1.45	2.26	1.26
Return on Equity (ROE)	9.49%	10.27%	9.87%	4.14%	2.39%	-16.47%
Return on Assets (ROA)	2.24%	2.27%	2.27%	1.66%	-0.07%	-2.13%
Return on Capital (ROIC)	2.57%	2.60%	2.60%	1.91%	-0.08%	-2.57%
Return on Capital Employed (ROCE)	4.00%	4.00%	4.10%	2.90%	-	-
Earnings Yield	6.98%	8.34%	7.77%	3.77%	1.51%	-14.42%
FCF Yield	-3.01%	-1.31%	-1.57%	1.30%	-8.77%	-23.54%
Buyback Yield / Dilution	-0.50%	-	0.15%	0.23%	-0.38%	0.38%
Total Shareholder Return	-	-	0.15%	0.23%	-0.38%	0.38%

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.